institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Published loading...Updated

Plasma Cell Removal Time

CAR-T therapy has the opportunity to go to parts where other therapies cannot reach. We know that anti-CD20 depletion inhibitngs relapsing disease and some parts of progressive MS, but what about d…
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

2 Articles

All
Left
Center
Right

A blood test could predict when multiple sclerosis patients are about to relapse into their symptoms, says a recent study. Infobae Blood levels of a protein called a light neurofilament chain increase significantly in MS patients up to one year before they have a relapse, researchers reported Monday at a meeting of the European Academy of Neurology in Helsinki. This type of early detection can help doctors prepare for a relapse, ensuring timely …

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

AlbertoNews - Periodismo sin censura broke the news in on Thursday, June 26, 2025.
Sources are mostly out of (0)